Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026

Same author

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

Nature cancer·2026

Same author

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026

Same author

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026

Same author

Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLC.

American journal of respiratory and critical care medicine·2026

Same author

New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspective.

Lung cancer (Amsterdam, Netherlands)·2026

Same journal

Kat5 deficiency in alveolar type II cells licenses STAT6-driven glycolytic reprogramming and pulmonary fibrosis.

Nature communications·2026

Same journal

Continuous nonthermal slab gap formed by progressive tearing beneath Northeast Asia.

Nature communications·2026

Same journal

Zeolitic isolated protonic acid sites-mediated NH<sub>3</sub> storage for robust NO<sub>x</sub> removal.

Nature communications·2026

Same journal

Coaxially nested component with asymmetric fiber resonant cavity and separation membrane for gaseous and dissolved gases detection.

Nature communications·2026

Same journal

Near-unity charge readout signal in a nonlinear resonator without matching the sensor dissipation.

Nature communications·2026

Same journal

Prokaryotic Schlafen proteins cleave tRNAs during type III CRISPR immunity.

Nature communications·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 20, 2025

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

Sarcoma classification by DNA methylation profiling.

Christian Koelsche^1,2,3, Daniel Schrimpf^1,2, Damian Stichel²

¹Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

Nature Communications

|January 22, 2021

Summary

This summary is machine-generated.

This study introduces a machine learning classifier using DNA methylation data to accurately diagnose various soft tissue and bone sarcomas. This approach aims to reduce misclassification and improve diagnostic reliability for these complex cancers.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Methyl-binding DNA capture Sequencing for Patient Tissues

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Related Experiment Videos

Last Updated: Nov 20, 2025

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Methyl-binding DNA capture Sequencing for Patient Tissues

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Area of Science:

Oncology
Genomics
Computational Biology

Background:

Sarcomas are heterogeneous malignant soft tissue and bone tumors with diagnostic challenges due to morphological variability.
High inter-observer variability and misclassification rates complicate accurate sarcoma diagnosis.
Current histopathological features are insufficient for definitive classification of all sarcoma subtypes.

Purpose of the Study:

To develop and validate a machine learning classifier for diagnosing soft tissue and bone sarcomas.
To leverage DNA methylation profiling for objective and reproducible sarcoma classification.
To improve diagnostic accuracy and reduce misclassification in sarcoma cases across all age groups.

Main Methods:

A machine learning classifier was developed using array-generated DNA methylation data.
The classifier was trained on 1077 methylation profiles from 62 pre-characterized tumor classes.
Performance was validated on an independent cohort of 428 sarcomatous tumors.

Main Results:

The DNA methylation-based classifier achieved successful classification of sarcomas.
322 out of 428 tested tumors were classified by the developed sarcoma classifier.
The study demonstrates high potential for DNA methylation profiling in sarcoma diagnostics.

Conclusions:

DNA methylation-based classification offers a robust method for diagnosing sarcomas.
This approach has the potential to significantly improve diagnostic accuracy and reduce variability.
The developed classifier shows promise for future clinical diagnostic applications in oncology.